InvestorsHub Logo
Followers 3
Posts 59
Boards Moderated 0
Alias Born 05/05/2022

Re: Ganz post# 15321

Tuesday, 05/17/2022 11:17:34 AM

Tuesday, May 17, 2022 11:17:34 AM

Post# of 17531
My opinion only and take it with a grain of Hollywood beach sand.
A buy out will happen, but now we have more of a diversified company with new compounds, AR 200 and AR 300, A ((someone)) company is waiting for some results in my opinion. Yes the drug Lupkynis will and is saving lives and is great no better, fantastic. The company is great with Lupy, but they diversified for some odd reason, and I believe the outcome will be more than $35 per share for Aurinia.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AUPH News